Skip to main content
. 2017 Mar 10;123(12):2294–2302. doi: 10.1002/cncr.30661

Table 2.

Tolerability Assessment of Toxicity by Interviewed Patients

AE Acceptable, No. (%) Slightly Unacceptable, No. (%) Unacceptable, No. (%) Totally Unacceptable, No. (%)
Alopecia
Limited 38 (63) 20 (33) 2 (3) 0 (0)
Important 20 (33) 27 (45) 9 (15) 4 (7)
Anorexia
Habitual nutrition
1‐7 d/mo 52 (88) 3 (5) 4 (7) 0 (0)
8‐14 d/mo 46 (78) 9 (15) 3 (5) 1 (2)
>15 d/mo 30 (51) 19 (32) 9 (15) 1 (2)
Decreased nutrition
1‐7 d/mo 52 (87) 4 (7) 3 (5) 1 (2)
8‐14 d/mo 43 (72) 12 (20) 4 (7) 1 (2)
>15 d/mo 28 (47) 18 (30) 12 (20) 2 (3)
Decreased nutrition + weight loss
1‐7 d/mo 38 (63) 12 (20) 6 (10) 4 (7)
8‐14 d/mo 20 (33) 25 (42) 11 (18) 4 (7)
>15 d/mo 10 (17) 20 (33) 21 (35) 9 (15)
Hospitalization
1‐7 d/mo 23 (38) 18 (30) 15 (25) 4 (7)
8‐14 d/mo 11 (18) 17 (28) 24 (40) 8 (13)
>15 d/mo 5 (8) 7 (12) 31 (52) 17 (28)
Diarrhea
Feces increase 1‐3 times/d
1‐7 d/mo 40 (67) 18 (30) 2 (3) 0 (0)
8‐14 d/mo 30 (50) 18 (30) 12 (20) 0 (0)
>15 d/mo 21 (35) 12 (20) 26 (43) 1 (2)
Feces increase 4‐6 times/d
1‐7 d/mo 23 (38) 15 (25) 17 (28) 5 (8)
8‐14 d/mo 7 (12) 24 (41) 18 (31) 10 (17)
>15 d/mo 6 (10) 10 (17) 26 (44) 17 (29)
Feces increase ≥ 7 times/d
1‐7 d/mo 6 (10) 17 (29) 17 (29) 19 (32)
8‐14 d/mo 3 (5) 6 (10) 25 (42) 25 (42)
>15 d/mo 3 (5) 5 (8) 24 (41) 27 (46)
Incontinence
1‐7 d/mo 6 (10) 16 (27) 21 (36) 16 (27)
8‐14 d/mo 5 (8) 3 (5) 29 (49) 22 (37)
>15 d/mo 4 (7) 3 (5) 25 (42) 27 (46)
Hospitalization
1‐7 d/mo 27 (46) 18 (31) 8 (14) 6 (10)
8‐14 d/mo 10 (17) 15 (25) 22 (37) 12 (20)
>15 d/mo 5 (8) 5 (8) 29 (49) 20 (34)
Mucositis
Slightly painful
1‐7 d/mo 51 (85) 7 (12) 2 (3) 0 (0)
8‐14 d/mo 44 (75) 9 (15) 5 (8) 1 (2)
>15 d/mo 36 (61) 11 (19) 9 (15) 3 (5)
Moderately painful
1‐7 d/mo 39 (66) 13 (22) 6 (10) 1 (2)
8‐14 d/mo 24 (41) 17 (29) 16 (27) 2 (3)
>15 d/mo 18 (31) 11 (19) 23 (39) 7 (12)
Painful
1‐7 d/mo 13 (22) 16 (27) 17 (29) 13 (22)
8‐14 d/mo 5 (8) 5 (8) 28 (47) 21 (36)
>15 d/mo 4 (7) 1 (2) 29 (49) 25 (42)
Hospitalization
1‐7 d/mo 32 (55) 10 (17) 11 (19) 5 (9)
8‐14 d/mo 9 (16) 15 (26) 24 (41) 10 (17)
>15 d/mo 7 (12) 2 (3) 34 (59) 15 (26)
Hand‐foot skin reaction
Slightly painful
1‐7 d/mo 51 (86) 6 (10) 1 (2) 1 (2)
8‐14 d/mo 44 (75) 10 (17) 4 (7) 1 (2)
>15 d/mo 38 (64) 11 (19) 7 (12) 3 (5)
Moderately painful
1‐7 d/mo 28 (47) 20 (34) 6 (10) 5 (8)
8‐14 d/mo 9 (15) 23 (39) 15 (25) 12 (20)
≥15 d/mo 4 (7) 11 (19) 28 (47) 16 (27)
Painful
1‐7 d/mo 7 (12) 10 (17) 23 (39) 19 (32)
8‐14 d/mo 2 (3) 2 (3) 31 (53) 24 (41)
≥15 d/mo 2 (3) 1 (2) 31 (53) 25 (42)
Hospitalization
1‐7 d/mo 30 (51) 14 (24) 7 (12) 8 (14)
8‐14 d/mo 11 (19) 15 (25) 19 (32) 14 (24)
≥15 d/mo 6 (10) 7 (12) 27 (46) 19 (32)
Arterial hypertension
Without treatment
1‐7 d/mo 56 (93) 2 (3) 2 (3) 0 (0)
8‐14 d/mo 55 (92) 2 (3) 3 (5) 0 (0)
≥15 d/mo 53 (88) 4 (7) 3 (5) 0 (0)
With 1 more treatment/d
1‐7 d/mo 52 (87) 4 (7) 4 (7) 0 (0)
8‐14 d/mo 51 (85) 5 (8) 4 (7) 0 (0)
≥15 d/mo 49 (82) 7 (12) 4 (7) 0 (0)
With 2 or 3 more treatments/d
1‐7 d/mo 38 (63) 12 (20) 9 (15) 1 (2)
8‐14 d/mo 32 (53) 15 (25) 11 (18) 2 (3)
≥15 d/mo 30 (50) 16 (27) 11 (18) 3 (5)
Hospitalization
1‐7 d/mo 35 (59) 9 (15) 11 (19) 4 (7)
8‐14 d/mo 14 (24) 11 (19) 23 (39) 11 (19)
≥15 d/mo 8 (14) 7 (12) 29 (49) 15 (25)
Asthenia
Without modification of activities
1‐7 d/mo 43 (93) 2 (4) 1 (2) 0 (0)
8‐14 d/mo 40 (87) 3 (7) 2 (4) 1 (2)
≥15 d/mo 34 (74) 5 (11) 5 (11) 2 (4)
Need rest at least half‐d/d
1‐7 d/mo 38 (83) 6 (13) 2 (4) 0 (0)
8‐14 d/mo 29 (63) 13 (28) 3 (7) 1 (2)
≥15 d/mo 19 (41) 15 (33) 8 (17) 4 (9)
Need rest more than half‐d/d
1‐7 d/mo 25 (54) 10 (22) 7 (15) 4 (9)
8‐14 d/mo 9 (20) 20 (43) 10 (22) 7 (15)
≥15 d/mo 4 (9) 10 (22) 19 (41) 13 (28)
Hospitalization
1‐7 d/mo 27 (59) 8 (17) 7 (15) 4 (9)
8‐14 d/mo 8 (17) 17 (37) 11 (24) 10 (22)
≥15 d/mo 5 (11) 3 (7) 23 (50) 15 (33)